(S)-methyl 2-((4-methoxybenzyl)amino)-2-phenylacetate | 909713-14-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-methyl 2-((4-methoxybenzyl)amino)-2-phenylacetate
• 英文别名: methyl (2S)-2-[(4-methoxyphenyl)methylamino]-2-phenylacetate
• CAS: 909713-14-0
• 化学式: C₁₇H₁₉NO₃
• 分子量: 285.343
• InChiKey: XKEIQSCGXGOULH-INIZCTEOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  21
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (S)-methyl 2-((4-methoxybenzyl)amino)-2-phenylacetate 在 sodium hydroxide 、 (叔丁基亚氨基)三(吡咯烷)膦 、 methyloxirane 作用下， 以 甲醇 、 二氯甲烷 、 乙腈 为溶剂， 生成
  参考文献：
  名称：

  β-Lactams derived from phenylalanine and homologues: effects of the distance between the aromatic rings and the α-stereogenic reactive center on the memory of chirality

  摘要：

  The enantioselectivity in the base-promoted cyclization of N-chloroacetyl derivatives of Phe, Phg, and Hph is dependent on the side-chain length, with the best results for Phg analogues (up to 74% ee). In contrast, shortening of the N-substituent, from a (p-methoxy)benzyl group to a (p-methoxy)phenyl moiety, led to a decrease in selectivity. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2006.06.057
• 作为产物：
  描述：

  甲基2-(苯基氨基)乙酸酯 、 4-甲氧基苯甲醛 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 生成 (S)-methyl 2-((4-methoxybenzyl)amino)-2-phenylacetate
  参考文献：
  名称：

  β-Lactams derived from phenylalanine and homologues: effects of the distance between the aromatic rings and the α-stereogenic reactive center on the memory of chirality

  摘要：

  The enantioselectivity in the base-promoted cyclization of N-chloroacetyl derivatives of Phe, Phg, and Hph is dependent on the side-chain length, with the best results for Phg analogues (up to 74% ee). In contrast, shortening of the N-substituent, from a (p-methoxy)benzyl group to a (p-methoxy)phenyl moiety, led to a decrease in selectivity. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2006.06.057

文献信息

• An efficient green protocol for the preparation of acetoacetamides and application of the methodology to a one-pot synthesis of Biginelli dihydropyrimidines. Expansion of dihydropyrimidine topological chemical space
  作者：Fernando H. S. Gama、Rodrigo O. M. A. de Souza、Simon J. Garden

  DOI：10.1039/c5ra14355a

  日期：——

  A one pot synthesis of Biginelli dihydropyrimidines. The novel use of the amino acids allows topological diversification of the chemical space.

  一锅法合成Biginelli双氢嘧啶化合物。氨基酸的新颖应用使化学空间具有拓扑多样性。
• Rh-catalyzed asymmetric hydrogenation of racemic aldimines via dynamic kinetic resolution
  作者：Dongyang Fan、Jian Lu、Yang Liu、Zhenfeng Zhang、Yangang Liu、Wanbin Zhang

  DOI：10.1016/j.tet.2016.07.046

  日期：2016.9

  Catalyzed by a rhodium complex of P-stereogenic diphosphine ligand trichickenfootphos (TCFP), asymmetric hydrogenation of racemic aldimines via dynamic kinetic resolution has been realized for the preparation of chiral arylglycines with good yields and enantioselectivities.

  通过P-立体异构二膦配体三Chickenfootphos（TCFP）的铑配合物的催化，已实现了通过动态动力学拆分的外消旋醛亚胺的不对称氢化，以制备具有良好收率和对映选择性的手性芳基甘氨酸。
• NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
  申请人：WILSON Kevin J.

  公开号：US20150258074A1

  公开（公告）日：2015-09-17

  Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).

  本发明揭示了具有吡唑吡啶基础结构的公式（1.0）的ERK抑制剂及其药学上可接受的盐。本发明还揭示了使用公式（1.0）的化合物治疗癌症的方法。
• Compounds that are ERK inhibitors
  申请人：Merck Sharp & Dohme Corp.

  公开号：US09226922B2

  公开（公告）日：2016-01-05

  Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).

  本发明涉及一种具有吡唑吡啶基结构的ERK抑制剂（式（1.0）），以及其药学上可接受的盐。本发明还涉及使用式（1.0）化合物治疗癌症的方法。
• US9226922B2
  申请人：——

  公开号：US9226922B2

  公开（公告）日：2016-01-05